Introduction
Opportunistic detection of coronary artery calcium (CAC) on routine, non-contrast chest CT is a scalable strategy for cardiovascular risk stratification — it uses scans that have already been performed for other reasons. But a practical question stands in the way of wide adoption: how reliable is automated CAC detection when it moves out of a single research setting and into heterogeneous, real-world clinical environments?
This study, presented at the 2026 Society of Cardiovascular Computed Tomography (SCCT) Annual Meeting by investigators from Brigham and Women’s Hospital, Massachusetts General Hospital, UT Southwestern, and other institutions, evaluated the agreement between Nanox.AI’s FDA-cleared coronary calcium algorithm (HealthCCSng) and expert visual assessment across three independent clinical sites. This page summarizes the design, headline results, and why cross-site reliability matters, and links to the full poster.
Key Takeaways
Study Overview
The study set out to evaluate agreement between an FDA-cleared AI CAC algorithm and expert visual assessment across multiple clinical sites, using clinically relevant CAC thresholds. Rather than measuring accuracy in a single controlled dataset, it tested how consistently the AI matched expert readers across heterogeneous, real-world imaging environments.
- Comparison: AI algorithm (automated scoring) versus expert reader (visual assessment).
- Sites: 3 independent clinical sites.
- Sample: 5,468 non-contrast chest CT studies.
- AI solution: Nanox.AI HealthCCSng (FDA-cleared).
- Framework: Agreement evaluated by site and by CAC category using clinically relevant thresholds.
Key Findings
Across the pooled analysis, AI-based CAC detection showed strong concordance with expert interpretation.
- Overall agreement exceeded 90% across all CAC categories.
- Agreement was reported by site and by CAC category, with performance color-graded (85–90%, 90–95%, ≥95%).
- For the CAC = 0 category, agreement was 99.0% at Site 1 and 96.2% at Site 3 — indicating the AI reliably identified scans with no detectable coronary calcium.
High agreement in the CAC = 0 category is clinically meaningful because correctly identifying the absence of calcium helps avoid unnecessary follow-up, while accurate detection of any calcium supports earlier preventive action.
Note: These are results presented in abstract/poster form (SCCT 2026). Category- and site-level figures beyond those shown here should be confirmed against the full poster and any peer-reviewed publication.
Why Cross-Site Reliability Matters
An AI tool is only useful for population-scale prevention if it performs consistently outside the lab.
- Real-world validation — testing across three independent sites reflects the variability of everyday clinical practice, not a single curated dataset.
- Consistency builds trust — high, stable agreement with expert readers supports clinician confidence in automated CAC scoring.
- Enables opportunistic screening — reliable AI analysis of routine CT scans lets health systems extract cardiovascular risk information from imaging already being performed.
- Supports preventive pathways — dependable CAC identification is the first step toward acting on incidental findings, as explored in the companion AI INFORM trial on preventive therapy.
FAQs
It measured the agreement between an FDA-cleared AI coronary artery calcium algorithm and expert radiologist visual assessment across three clinical sites and 5,468 non-contrast chest CT studies.
Overall agreement exceeded 90% across all CAC categories. For scans with no calcium (CAC = 0), agreement reached 99.0% at one site and 96.2% at another.
Performance can vary with scanner type, protocol, and patient population. Consistent agreement across independent sites indicates the AI is reliable in diverse real-world settings, not just a single dataset.
It is the practice of detecting coronary artery calcium on CT scans performed for non-cardiac reasons, allowing cardiovascular risk to be assessed without additional imaging or radiation.
Related Resources
- Nanox-AI On-Premise Interface (OPI): Integrating Bone Metrics Seamlessly
- The Fracture Liaison Service (FLS) Blueprint for Secondary Prevention
- Algorithmic Screening: Early Detection of Low BMD in General Populations
Client portal